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an 18-year period between January 1980 and December
1997. Of these patients, those who met the inclusion cri-
teria were selected for the study. The diagnosis of AAA was
established when the anteroposterior diameter of the
abdominal aorta, measured by means of either ultrasound
scanning or CT study, was greater than 50% of the undi-
lated infrarenal aortic diameter, according to the sug-
gested standards recommended by an ad hoc committee.8
Inclusion criteria
Three-dimensional–based data were obtained by
means of computer-aided 3D reconstruction from CT
studies of AAAs. Patients were included in the study
according to the inclusion criteria for CT studies. A nar-
row tomography slice gives a better quality 3D image of
an AAA. After evaluating the quality of 3D images recon-
structed from original CT studies with various slicing dis-
tances, we adopted a CT slicing distance between 5 and 15
mm for the study. For better visualization, contrast
enhancement in the original CT studies was necessary to
distinguish the aortic wall from surrounding tissues at data
input. We determined that a CT study interval of more
than 6 months was sufficient to show 3D morphologic
change with time.
Three-dimensional reconstruction
Our 3D reconstruction procedure was detailed by
Nunokawa et al.9 We used the commercially available soft-
ware “OZ” (Rise, Saitama Prefecture, Japan) on a
Bild/3D computer system (Computer Built, Tokyo,
Japan).
The procedure had three steps. The first step was
input of the aneurysmal image from each sequential CT
Patients with an atherosclerotic abdominal aortic
aneurysm (AAA) often have coexistent medical problems
because of their advanced age, smoking habits, and gener-
alized atherosclerosis. In such patients, the strategy for
treatment should weigh both the risk of rupture of the
present AAA and the severity of the coexistent medical
problems.1-6 However, information on the natural history
of AAAs is scarce, and risk factors for aneurysmal rupture
have not yet been established.7
Recent developments in computer technology have
made it possible to examine internal organs with three-
dimensional (3D) diagnostic techniques such as spiral
computed tomography (CT), magnetic resonance imag-
ing, and 3D-digital subtraction angiography.
The purpose of this study was to delineate the risk fac-
tors for the rupture of AAAs as evaluated by means of a
combination of 3D reconstruction and clinical data analysis.
METHODS
Patients
The study population comprised Japanese patients in
whom an atherosclerotic AAA had been diagnosed during
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Purpose: Factors influencing the development or rupture of abdominal aortic aneurysms (AAAs) have not yet been con-
firmed. This study delineated the risk factors for rupture of AAAs as evaluated by means of a combination of three-
dimensional (3D) reconstruction and clinical data analysis.
Methods: The study population comprised Japanese patients in whom an atherosclerotic AAA had been diagnosed
between January 1980 and December 1997. We obtained 3D-based data by means of computer-aided 3D reconstruc-
tion from computed tomography studies of AAAs. The data included the tortuosity of the aneurysm, maximum trans-
verse diameter, length of the aneurysm, aneurysmal volume, aneurysmal surface area, largest aneurysmal cross-sectional
area, ratio of transverse aneurysmal diameter to the length of the aneurysm (T/L), and amount of mural thrombus.
Clinical data were collected from patient files. All data were assessed by means of multivariate analysis for their pre-
dictive value for expansion or rupture of AAA.
Results: The most efficient predictor of annual expansion rate of maximum transverse diameter (EX-D) was a combi-
nation of largest aneurysmal cross-sectional area, tobacco use, and tortuosity. The most efficient predictor of annual
expansion rate of aneurysmal volume (EX-V) was a combination of aneurysmal volume and blood urea nitrogen level.
The most efficient predictors of aneurysmal rupture was a combination of EX-D, diastolic blood pressure, and T/L.
Conclusion: Three-dimensional–based data on aneurysmal morphology, including T/L, largest aneurysmal cross-
sectional area, and aneurysmal volume, had strong predictive value for expansion and rupture of AAAs. (J Vasc Surg
2001;33:453-61.)
slice on a digitizing pad. A frame of each slice was fixed to
the frame marked on the digitizer pad to secure the pre-
cise continuity of each slice image of the aneurysm. The
second step was data processing, in which the software cal-
culated the coordinates to build the whole 3D image. The
number of coordinates settled on was approximately 1 or
2 per 1 mm of mouse tracing. The X- and Y-coordinates
were calculated from the input aneurysmal slice image.
The Z-coordinates were calculated from the input slicing
distance and the order of each slice. The last step was 3D
image presentation on the display. The reconstructed 3D
image can be shown with a scale and rotated in any direc-
tion on the computer display.
The 3D-reconstruction software OZ can calculate the
volume, surface area, or cross-sectional area of the recon-
structed 3D image. When necessary, the inner structure of
the 3D image can be shown in fluoroscopic mode. The
mural thrombus of AAAs was shown by means of this
mode, and the amount of it was also calculated.
Study design
Clinical data. The patient record was retrospectively
reviewed to collect information on age; sex; height;
weight; tobacco use; systolic and diastolic blood pressure;
pulse pressure; coexistent diseases such as hypertension
(systolic blood pressure > 140 mm Hg or diastolic blood
pressure > 90 mm Hg or controlled with a drug), diabetes
mellitus (controlled by means of diet, oral drug, or
insulin), coronary artery diseases (history of angina,
myocardial infarction, or coronary artery bypass graft),
arteriosclerosis obliterans (diagnosed by means of pedal
pulses and symptoms), cerebrovascular disease (history of
transient or complete stroke), chronic obstructive pul-
monary disease (forced expiratory volume 1.0% < 50%),
renal failure (serum creatinine level > 3.0 mg/dL), and
liver disease; earlier laparotomy; laboratory data, including
cholesterol level, triglyceride level, urea nitrogen level,
creatinine level, fibrinogen level, fibrin degradation prod-
uct level, platelet count, and prothrombin time; symptoms
of AAA; rupture; and familial AAA.
Three-dimensional–based morphology data. The
maximum aneurysmal transverse diameter and length of
the aneurysm were measured on the reconstructed 3D
image by the use of the scale on the display. Because the
3D figures used for this purpose were not drawn in per-
spective, it was possible and valid to measure the diameter
and length with the scale on it. The length of the
aneurysm was defined as the length of a straight line
drawn through the center of the most proximal and most
distal cross section, in which the transverse aortic diameter
was at least 3 mm larger than the normal infrarenal aortic
diameter. Aneurysmal volume, aneurysmal surface area,
and largest aneurysmal cross-sectional area were calculated
by means of the OZ software. A volume value physically
measured was compared with the one calculated by means
of the software in 20 clay models of aneurysms to validate
the accuracy of volume measurement with this software.
As shown in Fig 1, A, the volume was defined as that of
the segment with the transverse diameter that was 3 mm
or more longer than the undilated infrarenal aorta. Surface
area was defined as the outer area of the segment, which
was defined as the aforementioned. The largest cross-
sectional area was defined as the one at the level of the
maximum transverse diameter of the aneurysm in the axial
plane (Fig 1, B).
In the 3D figures of AAA, tortuosities of the aorta and
the aneurysm were classified into three types while they
were examined, with a 3D image of the vessel axis drawn
by means of a function of the OZ software. A type of tor-
tuosity was defined as (1) a bent type when the axis of the
aorta and the aneurysm was on the same plane without
any element of spiral form, (2) a clockwise type when the
axis looked like a clockwise whorl when the aorta was
viewed from the cranial to caudal direction, or (3) a coun-
terclockwise type when the axis was opposite to the clock-
wise type (Fig 2).
We also measured the ratio of the transverse aneurys-
mal diameter to the length of the aneurysm (T/L; Fig 3).
The ratio of the maximum transverse diameter to the nor-
mal infrarenal aortic diameter (ROD) was also measured
on the 3D image.
An outstanding feature observed in the 3D images was
the varying amount of mural thrombus. To evaluate the
amount, we calculated the volume of mural thrombus
with the same 3D-reconstructing software, OZ. The
amount was classified as “much” when the amount of
mural thrombus was more than 50% of aneurysmal vol-
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Fig 1. Aneurysmal volume and surface area were measured for
segment with the transverse diameter that was 3 mm or more
longer than the undilated infrarenal aorta. A, Largest cross-
sectional area was defined as the one at the level of the maximum
transverse diameter of aneurysm in the axial plane (B).
A B
ume, “medium” when it was from 10% to 50% of aneurys-
mal volume, and “slight” when it was less than 10% of
aneurysmal volume.
To measure the change in an AAA with time, we cal-
culated the annual expansion rate of the maximum trans-
verse diameter of the aneurysm (EX-D) and that of the
aneurysmal volume(EX-V).
Statistical analysis
Both the clinical and 3D morphology-related data
were analyzed with the software “Lotus 123” and “123
Add In Statistics” (Social Information, Tokyo, Japan).
These data and either EX-D or EX-V were statistically ana-
lyzed as a means of assessing factors associated with
aneurysmal expansion. Risk factors for rupture of AAA
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were assessed by analyzing clinical data, 3D morphology-
related data, EX-D, and EX-V.
Laboratory data were categorized as either normal or
abnormal. They were statistically analyzed as both original
and categorized data. All data were quantified for regression
analyses. A single correlation coefficient for all clinical and
morphology-related data was calculated for either EX-D or
EX-V, and data that showed higher coefficient value were
selected. For the prevention of multicolinearity, variables
that had a high correlation coefficient for each other were
treated as one group, and more than two variables from
each group were not used in the multiple regression analy-
sis. Thus, variables that had a higher single correlation coef-
ficient for EX-D or EX-V and had little correlation with
each other were adopted for multiple regression analysis.
Fig 2. Spiral tortuosity of AAA. Spiral tortuosity seen in AAAs consisted of two types, counterclockwise clockwise (A, B,
C) and clockwise (D, E, F). B and E are cranial-to-caudal views of 3D images A and D, respectively. C and F show their
axes, which are counterclockwise and clockwise, respectively.
Clinical data, morphology-related data, EX-D, and
EX-V were assessed with a single correlation coefficient
for aneurysmal rupture. Again, data were selected to pre-
vent multicolinearity multivariate analysis. Risk factors for
aneurysmal rupture were analyzed in discriminant analysis.
Accuracy in this analysis meant the coincidence rate of
actual results, ruptured or nonruptured, and expected
results from the analysis. The correlation ratio was the r2
value in the discriminant analysis.
RESULTS
Thirty-nine patients with an atherosclerotic AAA met
the inclusion criteria and were included in the study (Table
I). The mean ± the SD values for the length of the follow-
up period was 31.8 ± 24.5 months and for the number of
CT studies was 2.9 ± 1.4 times. Eighteen patients were
operated on for an AAA, and seven patients had ruptured
AAAs. None of the 39 patients was lost to follow-up.
Neither clinical nor morphology-related data were signifi-
cantly different from those of our whole patient popula-
tion. The mean calculated volume value of clay models of
aneurysms was not significantly different from the mean
physically measured value (103.6 ± 5.3 cm3 vs 100.0 ± 0.0
cm3). The mean ± SD values for EX-D and EX-V were
0.31 ± 0.29 cm/y and 25.0 ± 28.7 cm3/y, respectively.
Factors associated with aneurysmal expansion of
maximum transverse diameter. Variables for which the sin-
gle correlation coefficient (r value) for EX-D was more than
0.5 included aneurysmal volume, maximum cross-sectional
area, aneurysmal surface area, maximum transverse diameter,
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Table I. Characteristics of 39 patients with an AAA who were involved in the study
Characteristic Value
Age (y) 75.8 ± 1.0
Sex
Men (%) 87.2
Women (%) 12.8
Height (cm) 157.4 ± 1.15
Body weight (kg) 52.7 ± 1.2
Ever smoked regularly (%) 47.1
Tobacco use (packs/day) 7.38 ± 1.44
Systolic blood pressure (mm Hg) 145.6 ± 3.0
Diastolic blood pressure (mm Hg) 81.0 ± 1.9
Pulse pressure (mm Hg) 64.6 ± 2.4
Hypertension (%) 64.7
Diabetes mellitus (%) 14.7
Coronary artery disease (%) 20.6
Arteriosclerosis obliterans (%) 44.1
Cerebrovascular disease (%) 20.6
Chronic obstructive pulmonary disease (%) 23.5
Renal failure (%) 23.5
Liver disease (%) 2.9
Serum cholesterol (mg/dL) 202.9 ± 6.71
Triglyceride (mg/dL) 134.2 ± 13.3
Urea nitrogen (mg/dL) 24.6 ± 2.63
Serum creatinine level (mg/dL) 1.85 ± 0.40
Fibrinogen (mg/dL) 261.4 ± 7.87
Platelet count (1000/mm3) 21.9 ± 0.82
Prothrombin time (%) 89.8 ± 1.68
Maximum transverse diameter (cm) 5.00 ± 1.43
Length of aneurysm (cm) 7.40 ± 2.83
Largest cross-sectional area (cm2) 19.1 ± 12.1
Aneurysmal surface area (cm2) 104.0 ± 58.0
Aneurysmal volume (cm3) 110.2 ± 92.2
Ratio of transverse to length of diameter (T/L) 0.72 ± 0.22
Tortuosity
Clockwise (%) 35.3
Counterclockwise (%) 38.2
Bent (%) 2.9
Ratio of maximal aneurysmal to infrarenal diameter (ROD) 1.90 ± 0.51
Infrarenal aortic diameter (cm) 2.67 ± 0.61
Symptomatic (%) 26.5
Earlier laparotomy (%) 52.9
Familial AAA (%) 2.9
Growth rate of maximal transverse diameter (cm/y) 0.311 ± 0.047
Growth rate of aneurysmal volume (cm3/y) 25.01 ± 4.67
Aneurysmal rupture (%) 20.6
length of the aneurysm, tobacco use, and tortuosity (Table
II). Aneurysmal volume, maximum cross-sectional area,
aneurysmal surface area, maximum transverse diameter, and
length of the aneurysm were treated as one group, because
they had higher single correlation coefficients for each other.
Multiple regression analysis was carried out among any sin-
gle variable of this group, tobacco use, or tortuosity (Table
III). As shown in equation A, the most efficient predictors
for EX-D were maximum cross-sectional area (X cm2),
tobacco use (Y = 1, smoker; Y = 0, nonsmoker), and tortu-
osity (Z = 1, counterclockwise; Z = 0, clockwise), with 0.72
of the decision coefficient (r 2 value; P = .0004).
(A) EX-D = 0.012X + 0.185Y + 0.184Z – 0.163
Factors associated with aneurysmal expansion of
aneurysmal volume. Variables for which the single corre-
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 3 Hatakeyama, Shigematsu, and Muto 457
lation coefficient for EX-V was more than 0.5 included
urea nitrogen level, serum creatinine level, ROD, maxi-
mum cross-sectional area, aneurysmal length of the
aneurysm, maximum transverse diameter, aneurysmal sur-
face area, and aneurysmal volume (Table II). Urea nitro-
gen and serum creatinine levels were treated as one group,
because they had higher single correlation coefficients for
each other. Also treated as one group were ROD, maxi-
mum cross-sectional area, aneurysmal length of the
aneurysm, maximum transverse diameter, aneurysmal sur-
face area, and aneurysmal volume. Multiple regression
analysis was carried out by the use of any single variable
from either group or any two variables from each of these
two groups (Table IV). As shown in equation B, the most
efficient predictors for EX-V were aneurysmal volume (X
cm3) and urea nitrogen level (mg/dL) with 0.71 of the
decision coefficient (r2 value; P = .0004).
Table II. Single correlation coefficient for EX-D, EX-V, and aneurysmal rupture
Variables EX-D EX-V Aneurysmal rupture
Age 0.118 –0.024 0.3555
Sex –0.009 0.208 0.0468
Height (cm) –0.365 0.037 –0.3520
Weight (kg) –0.181 0.004 –0.2290
Smoker/nonsmoker 0.572* 0.415 0.0374
Tobacco use (packs/day) 0.404 0.352 0.0064
Systolic blood pressure 0.022 0.231 0.2037
Diastolic blood pressure 0.242 0.346 0.4701
Pulse pressure –0.168 0.023 –0.1214
Hypertension 0.183 0.329 0.3750
Diabetes mellitus 0.216 –0.166 0.0546
Coronary artery disease 0.416 –0.102 0.2500
Arteriosclerosis obliterans 0.067 –0.234 –0.0403
Cerebrovascular disease –0.174 – 0.221 –0.2500
COPD 0.127 –0.158 –0.0468
Renal failure 0.140 0.265 0.1873
Liver disease –0.226 –0.090 –0.1021
Cholesterol –0.174 –0.240 –0.2374
Triglyceride 0.340 –0.010 0.2848
Urea nitrogen 0.373 0.594* 0.2139
Creatinine level 0.220 0.534† 0.0122
Fibrinogen –0.099 0.186 0.0225
Platelet count –0.196 –0.142 0.0315
Prothrombin time –0.230 –0.218 –0.0577
Maximum transverse diameter 0.657* 0.783* 0.4231†
Longitudinal diameter 0.620* 0.761* 0.0936
Largest cross-sectional area 0.634* 0.806* 0.5600*
Aneurysmal surface area 0.622* 0.836* 0.2316
Aneurysmal volume 0.667* 0.910* 0.4055†
T/L –0.235 –0.195 0.3675*
Tortuosity 0.514 0.031 –0.1217
ROD 0.361 0.517 0.3302
Infrarenal aortic diameter 0.422 0.447 0.2379
Rupture 0.540 0.301 0.2406
Previous laparotomy –0.184 0.189 0.0801
Familial AAA –0.224 –0.175 –0.0933
EX-D 0.5403†
EX-V 0.3008
*P < .01.
†P < .05.
COPD, Chronic obstructive pulmonary disease; T/L, ratio of transverse diameter to longitudinal diameter; ROD, ratio of the maximum transverse diame-
ter to the normal infrarenal aortic diameter; EX-D, expansion rate of maximal transverse diameter; EX-V, expansion rate of aneurysmal volume.
(B) EX-V = 0.203X + 267Y – 8.08
Factors associated with aneurysmal rupture.
Variables that had a higher single correlation coefficient
for aneurysmal rupture were age, diastolic blood pressure,
T/L, maximum cross-sectional area, and EX-D (Table II).
Maximum cross-sectional area and EX-D were treated as
one group, because they had higher single correlation
coefficients for each other. Discriminant analysis was made
with any single variable of this group, age, diastolic blood
pressure, or T/L (Table V). As shown in equation C, the
most efficient predictors for aneurysmal rupture were dias-
tolic blood pressure (X mm Hg), EX-D (Y cm/y), and
T/L (Z) with 95.8% of accuracy and 0.632 of the correla-
tion ratio (r2 value).
(C) R = 0.151X + 14.6Y + 17.2Z – 30.8
(R > 0, rupture; R < 0, nonrupture)
DISCUSSION
The results of this study revealed that aneurysmal rup-
ture and expansion in diameter or volume could be pre-
dicted more precisely by means of a combination of the
factors than by means of any single factor. For aneurysmal
rupture, the factors included EX-D, diastolic blood pressure,
and T/L. For expansion rate in diameter (EX-D), the factors
included cross-sectional area, tobacco use, and tortuosity.
For expansion rate in volume (EX-V), the factors included
aneurysmal volume and blood urea nitrogen level. Some of
the factors were known to be significant for aneurysmal
expansion or rupture, but some of them were not.
T/L is a novel factor that represent the longitudinal
expansion (Fig 3). When two aneurysms have the same
transverse diameters but different lengths, the one with a
higher T/L value can be said to have a more longitudinally
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Table III. Multiple regression analysis for EX-D
Combination of variables r2 value P value
T,H,C 0.693 .0001
T,H,R 0.675 .0002
T,H,V 0.638 .0005
H,C 0.611 .0002
H,R 0.599 .0003
T,H,S 0.575 .0019
H,V 0.562 .0006
T,H,L 0.540 .0036
T,R 0.499 .0020
T,C 0.494 .0022
H,S 0.481 .0027
T,H 0.471 .0032
T,V 0.471 .0032
H,L 0.450 .0046
T,S 0.423 .0071
T,L 0.407 .0091
R 0.336 .0059
H 0.314 .0082
V 0.312 .0085
C 0.307 .0092
T 0.291 .0117
L 0.262 .0178
S 0.248 .0215
C, Maximum cross-sectional area; H, tortuosity; L, aneurysmal longitudi-
nal diameter; R, maximum transverse diameter; S, aneurysmal surface area;
T, tobacco use; V, aneurysmal volume.
Table IV. Multiple regression analysis for EX-V
Combination of variables r2 value P value
b,V 0.8713 .00000001
c,V 0.8702 .00000001
V 0.8226 .00000001
b,S 0.7885 .00000085
c,C 0.7821 .00000111
c,S 0.7596 .00000268
b,C 0.7434 .00000482
c,R 0.7138 .00001287
b,R 0.6960 .00002217
S 0.6847 .00000370
b,L 0.6357 .00011303
C 0.6347 .00001546
R 0.5981 .00003934
c,L 0.5932 .00030522
L 0.5598 .00009597
b,r 0.5016 .00189643
c,r 0.4991 .00198563
b 0.3531 .00450025
c 0.2850 .01268805
r 0.2353 .02582899
b, Urea nitrogen level; c, serum creatinine level; r, ROD; C, maximum
cross-sectional area; L, aneurysmal longitudinal diameter; R, maximum
transverse diameter; S, aneurysmal surface area; V, aneurysmal volume.
Table V. Discriminant analysis for aneurysmal rupture
Combination of variables r2 value P value
b,t,E 0.6589 .0003
t,E 0.5762 .0004
a,b,t,E 0.6630 .0010
a,t,E 0.5790 .0017
t,C 0.4560 .0042
b,t,C 0.5016 .0069
t 0.3009 .0100
a,t,C 0.4628 .0126
b,t 0.3846 .0127
a,b,E 0.4509 .0150
a,b,t,C 0.5133 .0161
a,b,t 0.4347 .0189
b,E 0.3531 .0198
a,t 0.3464 .0218
C 0.2309 .0275
b,C 0.3214 .0305
a,b 0.3212 .0306
a,b,C 0.3928 .0333
a,C 0.2974 .0417
a,E 0.2931 .0441
a 0.1769 .0577
E 0.1767 .0577
b 0.1637 .0689
a, Age; b, diastolic blood pressure; t, T/L; C, maximum cross-sectional
area; E, EX-D.
stretched aneurysmal wall and, consequently, a more two-
dimensionally stretched wall than the one with a lower
T/L value. Since the time when Szilagyi et al reported that
diameter had an important bearing on the decision of oper-
ability, there have been many articles on the close relation
between size and rupture of AAAs.1,5,10-14 For the evalua-
tion of AAAs, maximal transverse diameter has been the
gold standard, whereas longitudinal expansion has hardly
been considered. The results of our study demonstrated
that the factor of longitudinal expansion represented as
T/L is significantly associated with aneurysmal rupture.
Ouriel et al15 demonstrated that “the saccular index” that
represented the ratio of the transverse diameter to the
length of AAA had no correlation to aneurysmal rupture.
The important difference between Ouriel’s study and ours
is the measurement of aneurysmal length with or without
3D reconstruction. We think this method is the most reli-
able means of measuring various values of AAA, such as
maximum transverse diameter, length, cross-sectional area,
or volume, because AAAs were so tortuous in 80% of cases
in this study that these values could be misinterpreted on
the planes of conventional imaging studies.
The growth rate of the transverse diameter of an AAA
(EX-D) was also one of three clues in predicting the rup-
ture of an AAA. Since Bernstein et al10 first introduced the
growth rate of AAA as a powerful tool for making decisions
about surgery, there have been numerous discussions
focusing on the subject. In their subsequent report, surgi-
cal resection was recommended for patients with smaller
AAAs who underwent follow-up ultrasonography when
the aneurysm grew rapidly (> 5 mm in 3 months) or symp-
toms developed.1 Gadowski et al16 studied the expansion
rate of AAA in patients prospectively monitored by means
of serial ultrasound scanning examination. They found that
the mean expansion rate was significantly greater in
patients with a ruptured AAA than in patients with an
unruptured AAA (0.82 ± 0.74 cm/y vs 0.42 ± 0.41 cm/y;
P = .04). Bengtsson et al17 studied the characteristics of the
aneurysm that influenced the rate of rupture by means of
the Cox proportional hazard method. They found that
diameter, length, and expansion rate of diameter had rela-
tive risks of 2.9, 3.4, and 2.3, respectively.
Diastolic blood pressure was another factor for pre-
dicting aneurysmal rupture in the study. The same results
were described by some authors. Cronenwett et al11 stud-
ied risk factors associated with the rupture of small AAAs
in patients initially selected for nonoperative treatment.
They identified diastolic blood pressure, initial anteropos-
terior diameter of the aneurysm, and degree of obstructive
pulmonary disease as being independently predictive of
rupture. In a retrospective study of patients with an AAA,
Foster et al3 found that rupture of the aneurysm was the
cause of death in 72% of patients with diastolic hyperten-
sion and an untreated abdominal aneurysm; however, they
did not conclude that diastolic hypertension had directly
contributed to the rupture.
Our results were comparable with these reports, which
demonstrated that a growth rate of an aneurysm or dias-
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tolic blood pressure was a risk factor for aneurysmal rup-
ture. However, our study results indicate the combination
of three factors were the most powerful means of predict-
ing aneurysmal rupture.
As for the cross-sectional area of aneurysm,
Cronenwett et al18 evaluated the elliptic cross-sectional
area as a indicator of aneurysmal size in patients with small
AAAs who were selected for nonoperative treatment and
followed up with sequential ultrasound scanning size mea-
surements. They found that a larger initial size, longer 
follow-up, and widened pulse pressure predicted larger
aneurysmal size at the final evaluation of the study. Wolf et
al19 studied the association between rapid expansion of
AAAs and CT scanning variables, including aneurysmal
cross-sectional area. The strongest predictor of the rapid
expansion was not aneurysmal cross-sectional area but an
increased thrombosed load.
Smoking is a well-evidenced risk factor for AAA or
aneurysmal expansion. In patients with small AAAs,
MacSweeney et al20 studied growth rates by means of ser-
ial ultrasound scanning. They found that growth rates
were higher in patients who continued to smoke (0.16 vs
0.09 cm/y in patients who no longer smoked, P = .038).
They concluded that the cessation of smoking could
reduce the growth rate of small AAAs.20 Cannon and
Read21 studied granular elastolytic activity in serum and
leukocytes in patients with and without atherosclerosis. In
smokers with AAAs, the activity was significantly
increased, whereas serum antiproteolytic capacity was
reduced compared with control nonsmokers and patients
Fig 3. The ratio transverse diameter to length of aneurysm
(T/L). The original aortoiliac segment (A) is shown with two
types of aneurysms, spindle (B) and spheric (C). The maximum
transverse diameter is identical, and circumferential tension is the
same between the two aneurysms. Focusing on the longitudinal
tension, segment a” is more stretched than segment a’ when
compared with the original segment a. This difference in longi-
tudinal tension is easy to evaluate by comparing the ratio T/L
(T’/L’ < T”/L”). The spheric type has advanced more in longi-
tudinal expansion than the spindle one, if the two aneurysms have
same transverse diameter.
with Leriche’s syndrome. They concluded that the devel-
opment of AAAs in patients who smoke correlates with an
abnormal homeostasis between proteolytic and antiprote-
olytic activity. Blue and Janof22 reported that human poly-
morphonuclear leukocytes released elastase when
incubated with cigarette smoke condensate and that the
enzyme remained active in the presence of condensate.
Cohen et al23 studied aortic elastase in rabbits divided into
cigarette-exposed and control groups. They found that
aortic elastase was significantly higher in the smoke-
exposed group than in both cage-control and machine-
control groups. They implied that patients with an AAA
who smoke may have an accelerated rate of aneurysm
growth, earlier rupture, or both. Auerbach and
Garfinkel24 reported that in autopsy series aneurysms were
found eight times more frequently among people smoking
one to two packets of cigarettes a day than in patients who
did not smoke. They stressed the association of cigarette
smoking with AAA. Hammond and Garfinkel25 did a
prospective epidemiologic study of more than 1 million
men and women. They found that death rates from aortic
aneurysm were low among patients who did not smoke
and increased greatly with the amount of cigarette smok-
ing. The Aneurysm Detection and Measurement (ADAM)
study demonstrated that smoking was the risk factor most
strongly associated with AAAs; the odds ratio for AAAs of
4.0 cm or larger compared with normal aortas was 5.57.26
In summary, smoking may have not only an initiating
effect, but also a promoting one. Our results point to the
latter effect of smoking.
We could find no data that supported the association
between tortuosity and aneurysmal enlargement. Infor-
mation on tortuosity is scarce, with the exception of the
suggestion of its correspondence with atherosclerosis.27
More information pertaining to the value of 3D tortuosity
may emerge from the development of a 3D study–based
diagnosis.
Factors that efficiently predicted EX-V included
aneurysmal volume and blood urea nitrogen level. This
result indicates that the initial aneurysmal size in volume
was an important factor; however, volume expansion as a
percentage of the original volume did not have better cor-
relation with the factors studied in this study. This might
be because another important factor, blood urea nitrogen,
has a significant role to predict aneurysmal expansion in
volume.
Balm et al28 studied the efficacy of measurement of
aortic lumen volume as a means of evaluating the results
of management of transfemoral endovascular aneurysm
repair. They advocated that the maximum aneurysm diam-
eter measurement, change in aortic lumen volume, and
the thrombus volume might be more appropriate means
of discriminating successful from failed exclusion. Again,
other information on aneurysmal volume was not found.
Data may emerge from future 3D-based studies.
The urea nitrogen level is elevated when protein
catabolism increases, such as in critically ill patients.29,30
An increased level of blood urea nitrogen may be associ-
ated with increased protein catabolism in aortic degenera-
tion caused by the development of end-stage atheroscle-
rosis, but our results show the need for a thorough
exploration of the possibility. There is no evidence for the
hypothesis.
In conclusion, this study demonstrated that the rup-
ture of AAAs could be precisely predicted by a combina-
tion of three factors, T/L, EX-D, and diastolic blood
pressure. T/L is a novel factor that represents the rate of
longitudinal aneurysmal expansion. EX-D could be cor-
rectly predicted by means of a combination of three fac-
tors, cross-sectional area, tobacco use, and tortuosity.
Factors associated with aneurysmal expansion are not
identical to those associated with aneurysmal rupture.
This might indicate that transverse diameter is no longer
the single important value for determining surgical indica-
tion. There is well-known evidence that small AAAs can
rupture.6 We think that further studies with 3D recon-
struction will reveal the important factor of aneurysmal
rupture, such as a significant bleb-like change on the
aneurysmal surface.
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